Short answer
Clorox (CLX) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.2). Clorox reported fiscal Q3 2026 results for the quarter ended March 31, 2026.
Clorox 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Clorox reported fiscal Q3 2026 results for the quarter ended March 31, 2026
- Full financial results and management commentary available in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Supplemental financial information furnished under Regulation FD via Exhibit 99.2
- Exhibit 99.2 contains the substantive disclosure investors should review for financial details
Item EX-99.1 · Exhibit EX-99.2
- Q3 sales $1.67B were flat, while organic sales declined 1%, signaling weak underlying demand despite portfolio stability
- Adjusted EPS rose 13% to $1.64, driven by cost savings and lower advertising and selling expenses
- Operating cash flow fell 59% to $282M, primarily reflecting the Glad joint venture termination payment
- FY2026 outlook weakened: sales down about 6%, organic sales down about 9%, and adjusted EPS $5.45–$5.65
- GOJO acquisition adds nearly 3 points of sales but dilutes adjusted EPS 2–4 cents and creates approximately 60 basis points of gross-margin headwind
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Clorox 8-K filings
Get the next CLX 8-K as it lands
Follow CLX for push alerts, or ask the research agent what this filing means.